Reduced levels of the survival of motor neurons protein (SMN), cause the inherited neuromuscular disorder, spinal muscular atrophy (SMA). The majority of therapeutic approaches to date have been focused on finding ways to increase expression of functional SMN protein, though stabilization of SMN protein may also be an important consideration. SMN interacts, directly or indirectly, stably or transiently, with a large number of other proteins, some of which contribute to SMN stability and may therefore be potential targets for SMA therapy. We recently characterized the nuclear SMN interactome using LC-MALDI-TOF/TOF analysis of anti-SMN pull-downs and identified myb-binding protein-1a (Mybbp1a) as a novel partner. In light of interest in cytoplasm-specific roles of the SMN complex, we have applied the same approach to characterise the cytoplasmic SMN interactome. We now show that SMN complexes from HeLa cytoplasmic extracts differ significantly from those found in nuclear extracts, with gemin5, importinbeta and annexin A2 easily detected only in the cytoplasmic extracts, whereas interaction of SMN with Mybbp1a appears to occur only in the nucleus. SMN is ubiquitinylated and we also found proteins of the ubiquitin-proteasome system associated with SMN in the cytoplasm.
introduction
The survival of motor neuron protein (SMN) is a ubiquitously expressed 40 kDa protein found in the cytoplasm, the nucleoplasm and in nuclear Cajal bodies [1] . Reduced levels of SMN cause spinal muscular atrophy (SMA), an autosomal recessive disease characterised by degeneration of motor neurons in the spinal cord [2] . SMN functions as a core complex with at least eight other proteins: gemin2 [3] (SIP-1), gemin3 (dp103, a putative RNA helicase) [4, 5] , gemin4 (which binds SMN indirectly through gemin3) [6] , and gemins 5 [7] , 6 [8] , 7 [9] , 8 [10] and unrip [11, 12] . This SMN complex appears to be involved in the assembly of U snRNPs in the cytoplasm and their subsequent transport into the nucleus [13] . There is evidence that SMN may also form other, compartmentspecific complexes, with different functions.
For example, SMN has been found in axons of motor neurons, associated with gemins but without snRNPs and far from any possible nuclear function [14, 15, 16] . The precise role of individual gemins is unclear, although it has been suggested that gemins 6 and 7 may structurally mimic Sm core proteins [15] and gemin5 is required for snRNA binding in the cytoplasm but may detach from the SMN complex when it reaches the Cajal body in the nucleus [17, 18] .
Whereas the SMN interactions with gemins are stable and possibly stoichiometric, others are expected to be transient and/or sub-stoichiometric, including the important functional interaction of SMN with coilin in Cajal bodies [19] . SMN may also interact with other proteins including the FUSE-binding protein (FBP) [20] , the Ewing's sarcoma (EWS) protein [21] , profilin [22] , fibrillarin [1, 23] , GAR1 [23] , hnRNPs U [1] , R [24] and Q [25] , nucleolin [26] , RNA helicase A [27] and myb-binding protein 1a [28] .
The severity of SMA correlates with SMN protein levels in humans and mice [29, 30, 31] , and so this gives reason to hope that drugs which produce quite modest increases in SMN might convert severely affected type I SMA babies into milder type II children, or allow type II children to survive as milder type III adults who can stand and walk [32] . However, without a basic understanding of SMN protein stability and dynamics, drug treatments that lead to increased SMN expression could be ineffective, especially if protein is degraded as quickly as it is synthesised [33] .
There is evidence that recruitment into SMN-gemin complexes stabilizes SMN, and in particular, gemin2 has been shown to play an important role in snRNP assembly through stabilization of the SMN oligomer/complex via novel self-interaction [34] . Other SMN-binding proteins have also been shown to regulate the stability of the SMN complex. Fibroblast growth factor-2 (FGF-2) competes with gemin2 for binding to SMN and may regulate Cajal body formation [35] . The nuclear phosphatase PPM1G interacts with and dephosphorylates the SMN complex, and in a mechanism that involves unrip, is required to maintain SMN subcellular distribution and stability [36] .
We recently characterised the nuclear SMN interactome using LC-MALDI-TOF/TOF analysis of anti-SMN pull-downs. Myb-binding protein1a, identified as a novel partner, is a mainly nucleolar protein of unknown function, but it partially co-localized with SMN in Cajal bodies and was reduced in cells from an SMA patient [28] . Since some SMN-interacting partners are known to be essential for the stability and known functions of the SMN complex, they may also be potential targets for SMA therapy.
In light of interest in cytoplasm-specific roles of the SMN complex, we have applied the same approach to characterise the cytoplasmic SMN interactome.
experimental procedures

Cell extraction
A HeLa cell pellet was extracted according to a protocol adapted from Dignam et al., [37] .
Briefly, 5x10 8 HeLa cells grown in suspension culture were collected by centrifugation, washed with PBS and homogenized in four volumes of 10 mM KCl, 10 mM Hepes-KOH pH 7.9, 1.5 mM MgCl 2 , 0.5 mM PMSF and 0.5 mM DTT using a Dounce homogeniser. The extract was then centrifuged for 10 minutes at 2,500 g to pellet the nuclei. The supernatant, containing cytoplasmic proteins, was carefully removed and centrifuged at 13,000 g for 10 minutes to remove any insoluble cell debris.
The nuclei were washed twice with the same resuspension buffer to remove any residual cytoplasm (10 mls each wash, 20 strokes with the Dounce homogenizer followed by centrifugation for 10 minutes at 2,500 g).
Washed nuclei were homogenized in 420 mM 
Protein identification by mass spectrometry
For mass spectrometry analysis, the beads with 
results
Many proteins can be immuno-precipitated non-specifically by antibodies attached to magnetic beads [42] . We have overcome this problem by performing control pull-downs with two different, unrelated monoclonal antibodies. Proteins found in either or both control pull-downs may be non-specific binders and were discarded from the SMN pull-down list. Proteins identified with a single peptide or with a total ion score confidence intervals of less than 95% were also rejected. Table 1 [12] and was also observed in nuclear complexes previously published [28] . was not pulled down with SMN in cytoplasmic extracts (Table 1) . Using a polyclonal antibody against mybbp1a, we were able to pull-down mybbp1a from both nuclear and cytoplasmic HeLa extracts, but SMN was only present in the nuclear immuno-precipitates ( Figure 1 ). This confirms that the association between SMN and mybbp1a occurs mainly in the nucleus.
discussion
We have shown that SMN complexes from
HeLa cytoplasmic extracts differ significantly from those found in nuclear extracts, with gemin5, importin-beta and annexin A2 easily Protein extracts from HeLa cells were subject to separation by SDS-PAGE and transferred to nitrocellulose by Western blotting. The blot was cut into horizontal strips and probed with antibodies against SMN (at 1/100 dilution) [38] and MYBBP1a (at 1/200 dilution) [41] , and visualized using a chemiluminescent system. 
Known components of snrNps Known components of snrNps * These proteins also appeared in one out of two pull-downs with control antibodies ** These proteins also appeared in two out of two pull-downs with control antibodies The proteins identified by LC-MALDI TOF/TOF analysis that co-immunoprecipitated with SMN are listed and arranged into different categories based on their published functions. "Peptides" refers to the number of peptides with both MS and MS/MS data that were used for identification. Proteins in italics are those rejected or considered unproven because they are single peptide hits, and/or they were also detected in control pull-downs (only shown for nuclear SMN interactome). The proteins listed in the "nuclear SMN interactome column" are those previously reported [28] .
continued Table 1 . Proteins identified by LC-MALDI TOF/TOF analysis in SMN immunoprecipitates.
* These proteins also appeared in one out of two pull-downs with control antibodies ** These proteins also appeared in two out of two pull-downs with control antibodies The proteins identified by LC-MALDI TOF/TOF analysis that co-immunoprecipitated with SMN are listed and arranged into different categories based on their published functions. "Peptides" refers to the number of peptides with both MS and MS/MS data that were used for identification. Proteins in italics are those rejected or considered unproven because they are single peptide hits, and/or they were also detected in control pull-downs (only shown for nuclear SMN interactome). The proteins listed in the "nuclear SMN interactome column" are those previously reported [28] . In view of the importance of the UPS in regulating SMN protein levels, it is of interest that several of the proteins identified in cytoplasmic pulldowns are related to the UPS and/or molecular chaperones. Sequestosome-1 is a ubiquitin-binding protein involved in protein degradation via the UPS [52] . Ubiquitinassociated protein-2 (UBAP2L) contains a UBAdomain (ubiquitin associated domain), which is a motif found in several proteins having connections to ubiquitin and the ubiquitination pathway [53] , and was identified by 8 peptides in the cytoplasmic pull-down (Table 1) . N-myc downstream regulated 1 (NDRG1) associated with the molecular chaperone, hsc70, in yeast two-hybrid screens [54] and hsc70 was also present in our pulldowns (Table 1) . NDRG1 is thought to have a role in growth arrest and cell differentiation, and to be particularly important in the peripheral nervous system, since mutations in the gene encoding NDRG1 cause hereditary motor and sensory neuropathies [55] .
Nuclear
We have shown previously that it is possible, using antibody pulldowns with appropriate controls, to identify novel potential SMN binding partners that are worthy of further study [28] . The data presented herein provides some novel insights, worthy of follow-up studies 
